Clinical performance of the AMDL DR-70 immunoassay kit for cancer detection.
A clinical study using DR-70 immunoassay for the detection of 13 different cancers have been conducted with 277 healthy subjects and 136 cancer patients. The test results showed that the DR-70 immunoassay kit was capable of detecting cancers with high degree of specificity and sensitivity. At 95% specificity level, the sensitivity of the assay was 87.8%, 92.6%, 65.2% and 66.7%, respectively for lung, stomach, breast and rectum cancers. Furthermore the test kits were shown to be stable and performed reproducibly.
Wu
D
D
Department of Clinical Laboratory, 2nd Affiliated Hospital, Hubei Medical University, Wuchang, Wuhan, China.
Zhou
X
X
Yang
G
G
Xie
Y
Y
Hu
M
M
Wu
Z
Z
Yang
G
G
Lu
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000175:diagnosis; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D008175:Lung Neoplasms / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000175:diagnosis*; D012372:ROC Curve; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity; D013274:Stomach Neoplasms / Q000175:diagnosis
D014408:Biomarkers, Tumor; D011933:Reagent Kits, Diagnostic